Weekly low-dose docetaxel combined with estramustine and dexamethasone for Japanese patients with metastatic castration-resistant prostate cancer

被引：0
作者：
Koji Hatano
Kazuo Nishimura
Yasutomo Nakai
Takahiro Yoshida
Mototaka Sato
Atsunari Kawashima
Masatoshi Mukai
Akira Nagahara
Motohide Uemura
Daizo Oka
Masashi Nakayama
Hitoshi Takayama
Kiyonori Shimizu
Norio Meguro
Tsuyoshi Tanigawa
Seiji Yamaguchi
Akira Tsujimura
Norio Nonomura
机构：
[1] Osaka University,Department of Urology, Graduate School of Medicine
[2] Osaka Medical Center for Cancer and Cardiovascular Diseases,Department of Urology
[3] Toyonaka Municipal Hospital,Department of Urology
[4] Osaka General Medical Center,Department of Urology
来源：
International Journal of Clinical Oncology | 2013年 / 18卷
关键词：
Castration-resistant prostate cancer; Docetaxel; Dexamethasone; Estramustine; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：704 / 710
页数：6
相关论文
共 90 条
  • [1] Tannock IF(2004)Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N Engl J Med 351 1502-1512
  • [2] de Wit R(2004)Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer N Engl J Med 351 1513-1520
  • [3] Berry WR(2007)Three-weekly docetaxel with prednisone is feasible for Japanese patients with hormone-refractory prostate cancer: a retrospective comparative study with weekly docetaxel alone Jpn J Clin Oncol 37 603-608
  • [4] Petrylak DP(2008)Docetaxel plus prednisolone for the treatment of metastatic hormone-refractory prostate cancer: a multicenter Phase II trial in Japan Jpn J Clin Oncol 38 365-372
  • [5] Tangen CM(2010)Docetaxel in combination with prednisolone for hormone refractory prostate cancer Jpn J Clin Oncol 40 79-84
  • [6] Hussain MH(2010)Docetaxel-prednisolone combination therapy for Japanese patients with hormone-refractory prostate cancer: a single institution experience Jpn J Clin Oncol 40 1092-1098
  • [7] Shimazui T(2010)Safety and efficacy of docetaxel, estramustine phosphate and hydrocortisone in hormone-refractory prostate cancer patients Int J Urol 17 629-634
  • [8] Kawai K(2008)Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study J Clin Oncol 26 242-245
  • [9] Miyanaga N(2000)Low doses of oral dexamethasone for hormone-refractory prostate carcinoma Cancer 89 2570-2576
  • [10] Naito S(2011)Retrospective analysis of an oral combination of dexamethasone, uracil plus tegafur and cyclophosphamide for hormone-refractory prostate cancer Jpn J Clin Oncol 41 253-259
123456789